文献速递腹部CT

基于增强CT的预测模型用于伴持续性器官衰竭的急性坏死性胰腺炎早期干预疗效及院内死亡风险预测

Contrast-enhanced CT-based prediction models for early intervention efficacy and in-hospital mortality risk in acute necrotizing pancreatitis with persistent organ failure.
PubMed 文献 · Eur Radiol · 2025-06-18

本研究回顾性分析164例伴持续性器官衰竭的急性坏死性胰腺炎患者,基于增强CT参数与SOFA评分构建列线图,预测早期干预疗效及院内死亡风险;早期干预疗效模型训练队列AUC为0.848(95%CI:0.769-0.927),验证队列为0.796(95%CI:0.644-0.947);院内死亡模型训练队列AUC为0.918(95%CI:0.864-0.971),验证队列为0.860(95%CI:0.801-0.919)。

要点

  • 早期干预疗效预测因子包括腹腔内压、心血管血流动力学变化及胰腺坏死体积增加。
  • 院内死亡预测因子包括SOFA评分、心血管血流动力学变化、右前肾旁间隙ANC平均CT值及左结肠旁沟CT值范围。
  • 模型在训练与验证队列均显示良好预测性能,可辅助筛选可能受益于早期干预的患者。

核心结论

  • 伴腹腔内高压或胰腺坏死体积显著增加但心血管血流动力学稳定的ANP合并POF患者更可能从早期干预中获益;SOFA评分升高、持续性心血管衰竭及ANC均匀性差或引流困难是院内死亡的危险因素。

研究设计与样本

  • 回顾性研究,纳入164例伴持续性器官衰竭的急性坏死性胰腺炎患者,训练队列110例,验证队列54例;采用SOFA评分评估器官功能障碍严重程度;增强CT参数包括急性坏死集合物各解剖区域的平均及范围CT值(HU)以及胰腺坏死体积;采用LASSO回归筛选预测因子,并通过ROC曲线、校准曲线及决策曲线分析评估列线图。

关键影像表现/征象

  • 急性坏死集合物(ANC)的CT值参数按解剖区域(右前肾旁间隙、左结肠旁沟等)分别测量平均CT值与范围CT值(HU)。
  • 胰腺坏死体积(PNV)增加被纳入早期干预疗效预测模型。
  • 右前肾旁间隙ANC平均CT值与左结肠旁沟CT值范围被纳入院内死亡预测模型。

诊断标准与关键数值

  • 早期干预疗效模型:训练队列AUC 0.848(95%CI:0.769-0.927),验证队列AUC 0.796(95%CI:0.644-0.947)。
  • 院内死亡模型:训练队列AUC 0.918(95%CI:0.864-0.971),验证队列AUC 0.860(95%CI:0.801-0.919)。

临床应用与阅片要点

  • 作者认为,整合器官功能障碍严重程度与增强CT影像特征的列线图可预测伴持续性器官衰竭的ANP患者的治疗反应和临床结局。
  • 作者指出,该预测模型可识别可能受益于早期有创干预的患者,并评估整个队列的院内死亡风险,为临床决策提供实用工具。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: To develop contrast-enhanced CT-based nomograms for predicting early intervention efficacy and in-hospital mortality in acute necrotizing pancreatitis (ANP) with persistent organ failure (POF).

MATERIALS AND METHODS: This retrospective study analyzed 164 ANP patients with POF (110 in the training cohort, 54 in the validation cohort). The Sequential Organ Failure Assessment (SOFA) score was used to evaluate organ dysfunction severity. Contrast-enhanced CT parameters included mean and range CT numbers (HU) of acute necrotic collections (ANC) across anatomical regions, as well as pancreatic necrosis volume (PNV). LASSO regression identified predictors for early intervention efficacy and mortality. Nomograms were assessed using receiver operating characteristic (ROC) curves, calibration curves, and decision curve analysis.

RESULTS: Early intervention efficacy predictors included intra-abdominal pressure, cardiovascular hemodynamic changes, and PNV increase. The model demonstrated good predictive performance, with an area under the ROC curve (AUC) of 0.848 (95% CI: 0.769-0.927) in the training cohort and 0.796 (95% CI: 0.644-0.947) in the validation cohort. In-hospital mortality predictors were SOFA score, cardiovascular hemodynamic changes, mean CT number of ANC at the right anterior pararenal space, and CT number range at the left paracolic gutter. The model showed AUCs of 0.918 (training cohort, 95% CI: 0.864-0.971) and 0.860 (validation cohort, 95% CI: 0.801-0.919).

CONCLUSION: ANP patients with intra-abdominal hypertension or significant PNV increase who maintain cardiovascular hemodynamic stability are more likely to benefit from early intervention. An elevated SOFA score, persistent cardiovascular failure, and ANC with poor homogeneity or drainage difficulty are risk factors for in-hospital mortality.

KEY POINTS: Question The optimal timing for early invasive intervention remains controversial in ANP with POF. Findings Nomogram models integrating organ dysfunction severity and contrast-enhanced CT imaging features can predict treatment response and clinical outcomes in ANP patients with POF. Clinical relevance Our prediction models can identify patients who may benefit from early invasive intervention and assess in-hospital mortality risk for the entire cohort, providing a practical tool to guide clinical decision-making.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Bu M, Zhang Y, Chen F, et al. Contrast-enhanced CT-based prediction models for early intervention efficacy and in-hospital mortality risk in acute necrotizing pancreatitis with persistent organ failure. Eur Radiol. 2025. PMID: 40531319. doi:10.1007/s00330-025-11766-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。